Charles River, a prominent player in the biological sciences sector, boasts a rich history of over 70 years. The company has distinguished itself with a comprehensive portfolio that spans biologics, cell therapy, and gene therapy, supporting development programs from research through to clinical and CMC testing support.

Headquartered in the United States, Charles River has become synonymous with innovation and reliability in cellular and gene therapy. The firm provides an integrated approach, aiding clients in the smooth transition from basic research phases to clinical application. This seamless support is indispensable in advancing the health sciences industry.

Industry Position

Charles River's prominence in the market is underscored by its capability to navigate the complex landscapes of biologics and gene therapies effectively. With a diversified skill set and cutting-edge facilities, the company has continuously pushed the boundaries of what's possible in therapeutic development. Key to its success is a robust infrastructure that aligns with the dynamic nature of gene therapy, positioning Charles River as a leader in this transformative field.

Trade Fairs & Exhibitions

Participation in industry trade fairs is pivotal to Charles River's strategy, enabling direct engagement with clients and showcasing the breadth of their expertise.

Trade Fairs & Exhibitions

Charles River participates in the following major trade fairs:

View Charles River's complete exhibition profile on TruLista

Market Strategy and Future Prospects

Charles River's active participation in high-profile exhibitions such as BIO '2026 and ASGCT 2025 highlights their commitment to maintaining visibility in the industry. These events offer invaluable opportunities to connect with stakeholders and update the market on their advancements. As the demand for innovative gene therapy solutions grows, Charles River's strong presence at these events underscores its adaptability and foresight in navigating future challenges in the biologics and therapeutics sectors.

Conclusion

Charles River's reputation for excellence is built on a foundation of robust expertise, strategic trade fair participation, and ongoing commitment to the evolution of biologics and gene therapy. As the company continues to play a pivotal role in industry transformation, its involvement in upcoming trade fairs will undoubtedly keep it at the forefront of innovation.